Graham Poage

Graham Poage has a diverse work experience spanning over 17 years. Graham most recently worked at Veracyte, Inc. as the Director of Market Access, a role they started in September 2022. Prior to that, they served as the Medical Science Liaison Director at Veracyte starting from August 2021 until September 2022.

Before joining Veracyte, Graham worked at HalioDx, the immune response to cancer diagnostics, as the Medical Science Liaison Director from March 2019 to August 2021.

Graham also held the position of Medical Science Liaison at bioTheranostics from October 2015 to March 2019. In this role, Graham supported medical and scientific affairs, educating healthcare providers and insurers about Medicare-covered molecular profiling tests for breast cancer and tumor tissue origin identification.

Earlier in their career, Graham worked as the Laboratory Director at San Antonio Military Medical Center from October 2014 to October 2015.

Graham also gained research experience as a Postdoctoral Fellow at The University of Texas - MD Anderson Cancer Center from July 2011 to August 2014.

During their time as a predoctoral student at Brown University from 2006 to 2011, Graham focused on their studies.

Graham'scareer began at Novartis, where they served as a Scientific Associate based in Cambridge, MA, contributing to the Global Discovery Chemistry groups. Graham'sresponsibilities included managing the chemical database and implementing strategies to optimize laboratory research.

Overall, Graham Poage has demonstrated expertise in market access, medical science liaison roles, and scientific research across various healthcare and pharmaceutical organizations.

Graham Poage obtained their Bachelor of Arts degree in Chemistry-Biochemistry, Cell and Molecular Biology, and Physics from Colby College, where they studied from 2000 to 2004. During their undergraduate years, they also participated in a study abroad program at University College Cork in 2002-2003, focusing on Biochemistry. Following their undergraduate studies, Graham pursued a Doctor of Philosophy (Ph.D.) in Molecular Pharmacology and Physiology at Brown University, which they completed between 2006 and 2011.